Skip to main content
. 2011 Feb 8;5:77–84. doi: 10.2147/DDDT.S15788

Table 1.

Treatment Group Properties

Group Sensitization Allergen challenge Treatment Early phase n Late phase n
1 No treatment (NS/NC) 8 8
2 + + No treatment (S/C) 8 8
3 + + Alcaftadine vehicle 8 8
4 + + Olopatadine 0.1% 8 8
5 + + alcaftadine 0.25% 8 8

Abbreviations: NS/NC, no sensitization, no challenge (naïve animals); S/C, sensitized, challenged.